Efficacy Study of CPC634 (CriPec ® Docetaxel) in Platinum Resistant Ovarian Cancer
Conditions: Cancer; Ovarian Cancer Intervention: Drug: CPC634 (CriPec® docetaxel) Sponsor: Cristal Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Docetaxel | Ovarian Cancer | Ovaries | Research | Study | Taxotere